In the Clinic: Identifying & Managing HCV Complications

Volume 6, Issue 2

In the Clinic: Identifying & Managing HCV Complications

In this issue:

Among the many extrahepatic complications of hepatitis C infection that contribute to increased morbidity and mortality are CV (cryoglobulinemic vasculitis) and CKD chronic kidney disease).

In this issue, Dr. Paul Martin and Dr. Kalyan Ram Bhamidimarri from the Miller School of Medicine at the University of Miami discuss identification and management of these HCV-related comorbidities.

Learning objectives:

Identify, diagnose and manage hepatitis C-associated vasculitis.
Describe the changing management strategies in solid organ transplantation, including the use of organs from HCV positive and HIV positive donors.

Authors:

Paul Martin, MD, FRCP, FRCPI

Professor of Medicine, Chief Division of Gastroenterology/Hepatology
University of Miami School of Medicine
Miami, Florida

Kalyan Ram Bhamidimarri, MD, MPH
Associate Professor of Clinical Medicine
Medical Director for Small Bowel & Multi-Visceral Transplantation
University of Miami School of Medicine
Miami Transplant Institute
Miami, Florida

Guest Faculty Disclosures

Dr. Martin has disclosed that he has served as a principal investigator and consultant for Gilead Sciences, Inc., AbbVie, Inc., and Merck & Co, Inc.

Dr. Bhamidimarri has disclosed that he has served as a principal investigator on a scientific advisory board for Gilead Sciences, Inc. He has also served as a principal investigator for Mallinckrodt, Inc. and Vital Therapies. He has served on scientific advisory boards for Abbott Laboratories, Intercept, and Merck & Co., Inc. And he has received consulting fees from Alexion.

Unlabeled/Unapproved Uses

Dr. Martin and Dr. Bhamidimarri have indicated that there will be no references to the unlabeled or unapproved uses of any drugs or products.

Program Directors:

Mark S. Sulkowski, MD

Professor of Medicine
Division of Infectious Diseases
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology and Hepatology
Johns Hopkins School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD

Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP

The Johns Hopkins Hospital
Baltimore, Maryland

Guest Faculty Disclosures:

Dr. Martin has disclosed that he has served as a principal investigator and consultant for Gilead Sciences, Inc., AbbVie, Inc., and Merck & Co, Inc.

Unlabeled/Unapproved Uses:

Dr. Martin and Dr. Bhamidimarri have indicated that there will be no references to the unlabeled or unapproved uses of any drugs or products.

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: October 26, 2018
Expiration date: October 25, 2020

Start Issue